Cannara Biotech Inc (LOVE.CA) Stock Fundamental Analysis

TSX-V:LOVE • CA13765U2002

1.87 CAD
-0.02 (-1.06%)
Last: Mar 2, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

LOVE gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 2 industry peers in the Personal Care Products industry. LOVE has an average financial health and profitability rating. LOVE has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination!


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • LOVE had positive earnings in the past year.
  • In the past year LOVE had a positive cash flow from operations.
  • LOVE had positive earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: LOVE reported negative operating cash flow in multiple years.
LOVE.CA Yearly Net Income VS EBIT VS OCF VS FCFLOVE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M -20M -30M

1.2 Ratios

  • LOVE has a Return On Assets of 6.79%. This is amongst the best in the industry. LOVE outperforms 100.00% of its industry peers.
  • LOVE has a Return On Equity of 10.62%. This is comparable to the rest of the industry: LOVE outperforms 50.00% of its industry peers.
Industry RankSector Rank
ROA 6.79%
ROE 10.62%
ROIC N/A
ROA(3y)5.61%
ROA(5y)3.4%
ROE(3y)9.61%
ROE(5y)5.98%
ROIC(3y)N/A
ROIC(5y)N/A
LOVE.CA Yearly ROA, ROE, ROICLOVE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150 -200

1.3 Margins

  • LOVE's Profit Margin of 10.51% is amongst the best of the industry. LOVE outperforms 100.00% of its industry peers.
  • In the last couple of years the Profit Margin of LOVE has grown nicely.
  • With a Gross Margin value of 17.92%, LOVE perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
  • In the last couple of years the Gross Margin of LOVE has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 10.51%
GM 17.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y23.91%
PM growth 5YN/A
GM growth 3Y-2.22%
GM growth 5Y-23.98%
LOVE.CA Yearly Profit, Operating, Gross MarginsLOVE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • LOVE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • LOVE has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, LOVE has more shares outstanding
  • LOVE has a better debt/assets ratio than last year.
LOVE.CA Yearly Shares OutstandingLOVE.CA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
LOVE.CA Yearly Total Debt VS Total AssetsLOVE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • An Altman-Z score of 2.59 indicates that LOVE is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.59, LOVE is in line with its industry, outperforming 50.00% of the companies in the same industry.
  • The Debt to FCF ratio of LOVE is 2.53, which is a good value as it means it would take LOVE, 2.53 years of fcf income to pay off all of its debts.
  • With an excellent Debt to FCF ratio value of 2.53, LOVE belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • LOVE has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.29, LOVE belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 2.53
Altman-Z 2.59
ROIC/WACCN/A
WACC7.46%
LOVE.CA Yearly LT Debt VS Equity VS FCFLOVE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M 80M 100M

2.3 Liquidity

  • LOVE has a Current Ratio of 2.70. This indicates that LOVE is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of LOVE (2.70) is better than 100.00% of its industry peers.
  • LOVE has a Quick Ratio of 1.05. This is a normal value and indicates that LOVE is financially healthy and should not expect problems in meeting its short term obligations.
  • LOVE has a Quick ratio (1.05) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.7
Quick Ratio 1.05
LOVE.CA Yearly Current Assets VS Current LiabilitesLOVE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

9

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 76.50% over the past year.
  • LOVE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 75.27% yearly.
  • LOVE shows a strong growth in Revenue. In the last year, the Revenue has grown by 28.06%.
  • The Revenue has been growing by 110.79% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)76.5%
EPS 3Y75.27%
EPS 5YN/A
EPS Q2Q%-57.14%
Revenue 1Y (TTM)28.06%
Revenue growth 3Y43.92%
Revenue growth 5Y110.79%
Sales Q2Q%20.11%

3.2 Future

  • Based on estimates for the next years, LOVE will show a very strong growth in Earnings Per Share. The EPS will grow by 41.42% on average per year.
  • The Revenue is expected to grow by 16.79% on average over the next years. This is quite good.
EPS Next Y60%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year22.42%
Revenue Next 2Y16.79%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
LOVE.CA Yearly Revenue VS EstimatesLOVE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M
LOVE.CA Yearly EPS VS EstimatesLOVE.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0.05 0.1 0.15 0.2

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 14.38, which indicates a correct valuation of LOVE.
  • Based on the Price/Earnings ratio, LOVE is valued cheaper than 100.00% of the companies in the same industry.
  • LOVE's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.13.
  • With a Price/Forward Earnings ratio of 9.26, the valuation of LOVE can be described as very reasonable.
  • 100.00% of the companies in the same industry are more expensive than LOVE, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of LOVE to the average of the S&P500 Index (28.11), we can say LOVE is valued rather cheaply.
Industry RankSector Rank
PE 14.38
Fwd PE 9.26
LOVE.CA Price Earnings VS Forward Price EarningsLOVE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • LOVE's Price/Free Cash Flow ratio is rather cheap when compared to the industry. LOVE is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.01
EV/EBITDA N/A
LOVE.CA Per share dataLOVE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

  • LOVE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as LOVE's earnings are expected to grow with 41.42% in the coming years.
PEG (NY)0.24
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for LOVE!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

Cannara Biotech Inc

TSX-V:LOVE (3/2/2026, 7:00:00 PM)

1.87

-0.02 (-1.06%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)01-26
Earnings (Next)04-27
Inst Owners0.23%
Inst Owner ChangeN/A
Ins Owners27.98%
Ins Owner ChangeN/A
Market Cap179.11M
Revenue(TTM)112.36M
Net Income(TTM)11.81M
Analysts80
Price Target3.57 (90.91%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)16.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)5.05%
Revenue NY rev (3m)5.05%
Valuation
Industry RankSector Rank
PE 14.38
Fwd PE 9.26
P/S 1.59
P/FCF 13.01
P/OCF 8.09
P/B 1.61
P/tB 1.61
EV/EBITDA N/A
EPS(TTM)0.13
EY6.95%
EPS(NY)0.2
Fwd EY10.8%
FCF(TTM)0.14
FCFY7.69%
OCF(TTM)0.23
OCFY12.36%
SpS1.17
BVpS1.16
TBVpS1.16
PEG (NY)0.24
PEG (5Y)N/A
Graham Number1.84
Profitability
Industry RankSector Rank
ROA 6.79%
ROE 10.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 10.51%
GM 17.92%
FCFM 12.25%
ROA(3y)5.61%
ROA(5y)3.4%
ROE(3y)9.61%
ROE(5y)5.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y23.91%
PM growth 5YN/A
GM growth 3Y-2.22%
GM growth 5Y-23.98%
F-Score8
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 2.53
Debt/EBITDA N/A
Cap/Depr 124.72%
Cap/Sales 7.45%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 116.58%
Current Ratio 2.7
Quick Ratio 1.05
Altman-Z 2.59
F-Score8
WACC7.46%
ROIC/WACCN/A
Cap/Depr(3y)124.47%
Cap/Depr(5y)353.96%
Cap/Sales(3y)9.79%
Cap/Sales(5y)49.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)76.5%
EPS 3Y75.27%
EPS 5YN/A
EPS Q2Q%-57.14%
EPS Next Y60%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)28.06%
Revenue growth 3Y43.92%
Revenue growth 5Y110.79%
Sales Q2Q%20.11%
Revenue Next Year22.42%
Revenue Next 2Y16.79%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y52.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year81.75%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y702.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y262.58%
OCF growth 3YN/A
OCF growth 5YN/A

Cannara Biotech Inc / LOVE.CA FAQ

What is the fundamental rating for LOVE stock?

ChartMill assigns a fundamental rating of 6 / 10 to LOVE.CA.


What is the valuation status of Cannara Biotech Inc (LOVE.CA) stock?

ChartMill assigns a valuation rating of 7 / 10 to Cannara Biotech Inc (LOVE.CA). This can be considered as Undervalued.


What is the profitability of LOVE stock?

Cannara Biotech Inc (LOVE.CA) has a profitability rating of 4 / 10.


Can you provide the financial health for LOVE stock?

The financial health rating of Cannara Biotech Inc (LOVE.CA) is 6 / 10.


Can you provide the expected EPS growth for LOVE stock?

The Earnings per Share (EPS) of Cannara Biotech Inc (LOVE.CA) is expected to grow by 60% in the next year.